Brian Corvese
CIK 1393207 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$575.2K
Companies
3
Total Filings
49
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-05 | INKT | Grant (A) | +21,802 | $17.9K | EDGAR |
| 2024-06-18 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | INKT | Grant (A) | +17,967 | $17.8K | EDGAR |
| 2024-04-22 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2024-03-29 | Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | INKT | Grant (A) | +18,816 | $17.9K | EDGAR |
| 2023-12-05 | INKT | Grant (A) | +17,188 | $17.9K | EDGAR |
| 2023-09-06 | INKT | Grant (A) | +12,244 | $17.9K | EDGAR |
| 2023-06-16 | INKT | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | INKT | Grant (A) | +10,157 | $17.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.